Loading viewer...
earnings
Format: PDF earnings
Acadia Pharmaceuticals' fourth quarter and full year 2025 earnings presentation delivered February 25, 2026. The call covers commercial updates on flagship products NUPLAZID and DAYBUE, R&D progress, and financial results for the fiscal year.
presentation
earnings
41 Pages
LKQ Corporation
Ford Motor Company Q2 2016 Earnings Review
earningsearnings
50 Pages
Ford Motor Company
Alnylam Pharmaceuticals 2022 Q4 Earnings Financial Results
earningsearnings
29 Pages
Alnylam Pharmaceuticals